A Reversal for ABCAM PLC (OTCMKTS:ABCZF) Is Near. The Stock Has Decrease in Shorts

February 4, 2018 - By Henry Gaston

The stock of ABCAM PLC (OTCMKTS:ABCZF) registered a decrease of 6.67% in short interest. ABCZF’s total short interest was 40,600 shares in February as published by FINRA. Its down 6.67% from 43,500 shares, reported previously. With 4,300 shares average volume, it will take short sellers 9 days to cover their ABCZF’s short positions.

The stock decreased 0.79% or $0.14 during the last trading session, reaching $17.55. About 2,500 shares traded. Abcam Plc (OTCMKTS:ABCZF) has 0.00% since February 4, 2017 and is . It has underperformed by 16.70% the S&P500.

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company has market cap of $3.26 billion. The firm primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents. It has a 59.29 P/E ratio. The Company’s products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as well as in drug discovery services and products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: